日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Standardizing Safety Assessment and Reporting for Neonatal Clinical Trials

新生儿临床试验安全评估和报告的标准化

Davis, Jonathan M; Baer, Gerri R; McCune, Susan; Klein, Agnes; Sato, Junko; Fabbri, Laura; Mangili, Alexandra; Short, Mary A; Tansey, Susan; Mangum, Barry; Hokuto, Isamu; Nakamura, Hidefumi; Salaets, Thomas; Allegaert, Karel; Yao, Lynne; Blum, Michael; Toerner, Joseph; Turner, Mark; Portman, Ron

Editorial Commentary: A Collaborative Model for Endpoint Development: Advancing the Science of Antibacterial Drug Clinical Trials

社论评论:终点指标开发的协作模式:推进抗菌药物临床试验的科学发展

Toerner, Joseph G; Cox, Edward

Patient and physician attitudes regarding risk and benefit in streamlined development programmes for antibacterial drugs: a qualitative analysis

患者和医生对抗菌药物精简研发项目中风险和获益的态度:一项定性分析

Holland, Thomas L; Mikita, Stephen; Bloom, Diane; Roberts, Jamie; McCall, Jonathan; Collyar, Deborah; Santiago, Jonas; Tiernan, Rosemary; Toerner, Joseph

Estimation of the effect of neutropenia on rates of clinical bacteraemia in HIV-infected patients

评估中性粒细胞减少症对 HIV 感染患者临床菌血症发生率的影响

Caperna, J; Barber, R E; Toerner, J G; Mathews, W C